1. Home
  2. LGVN

LGVN

Longeveron Inc.

Logo Longeveron Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-24-2024 3:59pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Founded: 2014 Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: 16.9M IPO Year: 2021
Target Price: $103.33 AVG Volume (30 days): 2.1M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -10.20 EPS Growth: N/A
52 Week Low/High: $1.62 - $44.00 Next Earning Date: 05-10-2024
Revenue: $709,000 Revenue Growth: -41.98%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: